World Journal of Surgery

, Volume 43, Issue 4, pp 1029–1037 | Cite as

Percutaneous Microwave Ablation of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma: Preliminary Results

  • Wei Zhou
  • Yudong Chen
  • Lu Zhang
  • Xiaofeng Ni
  • Shangyan Xu
  • Weiwei ZhanEmail author
Original Scientific Report



Our purpose is to assess the effectiveness and safety of ultrasound-guided percutaneous microwave ablation (MWA) for lymph node metastases (LNMs) from papillary thyroid carcinomas (PTC).


In total, 14 patients with recurrent PTC were enrolled in this retrospective study. The vascularity within the ablation zone was evaluated by contrast-enhanced ultrasonography (CEUS) after MWA. Patients were followed up with measurement of the size and volume of tumor, serum thyroglobulin, and clinical evaluation at 7 days, 1, 3, 6 months, and every 6 months thereafter.


Twenty-one LNMs were confirmed by biopsy and successfully treated by MWA in a single session. No incomplete ablation was detected by CEUS after treatment. The average largest diameter and volume of the tumors were reduced from 10.1 ± 4.7 mm (range, 3.1–20.0 mm) and 291.9 ± 255.6 mm3 (range, 11.6–766.6 mm3) to 0.9 ± 1.6 mm (range, 0–4.1 mm; p < 0.05) and 4.0 ± 9.0 mm3 (range, 0–31.6 mm3; p < 0.05) at the final follow-up. Neither progression of treated tumors nor newly suspicious LNMs could be detected after treatment. The overall complication rate was 7.1% (1/14).


Ultrasound-guided MWA can effectively control LNMs from PTC, but it is less safe for tumors in the central compartment. MWA may become an alternative therapy in selected PTC patients, who were ineligible or refused to undergo repeated neck explorations.



Lymph node metastases


Papillary thyroid carcinoma




Contrast-enhanced ultrasonography


Microwave ablation


Fine-needle aspiration biopsy



This work was supported by Grants from the Capacity building project of auxiliary department (Ultrasonic Medicine), clinical science and technology innovation project from Shanghai Shen Kang Hospital Development Center (No. SHDC22015006).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Johnson NA, Tublin ME (2008) Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Radiology 249:429–444CrossRefPubMedGoogle Scholar
  2. 2.
    DeGroot LJ, Kaplan EL, McCormick M et al (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–424CrossRefPubMedGoogle Scholar
  3. 3.
    Burman KD (2012) Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: deceptively simple options. J Clin Endocrinol Metab 97:2623–2625CrossRefPubMedGoogle Scholar
  4. 4.
    Frasoldati A, Pesenti M, Gallo M et al (2003) Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90–96CrossRefPubMedGoogle Scholar
  5. 5.
    Samaan NA, Schultz PN, Hickey RC et al (1992) The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714–720PubMedGoogle Scholar
  6. 6.
    Heilo A, Sigstad E, Fagerlid KH et al (2011) Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab 96:2750–2755CrossRefPubMedGoogle Scholar
  7. 7.
    Zhou W, Zhang L, Zhan W et al (2016) Percutaneous laser ablation for treatment of locally recurrent papillary thyroid carcinoma < 15 mm. Clin Radiol 71:1233–1239CrossRefPubMedGoogle Scholar
  8. 8.
    Zhang L, Zhou W, Zhan W (2018) Role of ultrasound in the assessment of percutaneous laser ablation of cervical metastatic lymph nodes from thyroid carcinoma. Acta Radiol 59:434–440CrossRefPubMedGoogle Scholar
  9. 9.
    Kim JH, Yoo WS, Park YJ et al (2015) Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology 276:909–918CrossRefPubMedGoogle Scholar
  10. 10.
    Li X, Liang P, Yu J et al (2013) Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma. Radiol Oncol 47:398–404CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Qu P, Yu X, Liang P et al (2013) Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging. Ultrasound Med Biol 39:1571–1579CrossRefPubMedGoogle Scholar
  12. 12.
    Belfiore G, Ronza F, Belfiore MP et al (2013) Patients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol 82:177–181CrossRefPubMedGoogle Scholar
  13. 13.
    Yue W, Wang S, Yu S et al (2014) Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperth 30:150–157CrossRefGoogle Scholar
  14. 14.
    Yue W, Chen L, Wang S et al (2015) Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: a prospective study. Int J Hyperth 31:403–408CrossRefGoogle Scholar
  15. 15.
    Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Robenshtok E, Fish S, Bach A et al (2012) Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab 97:2706–2713CrossRefPubMedGoogle Scholar
  17. 17.
    Rondeau G, Fish S, Hann LE et al (2011) Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid 21:845–853CrossRefPubMedGoogle Scholar
  18. 18.
    Guenette JP, Monchik JM, Dupuy DE (2013) Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J Vasc Interv Radiol 24:672–679CrossRefPubMedGoogle Scholar
  19. 19.
    Guang Y, Luo Y, Zhang Y et al (2017) Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma. J Cancer Res Clin Oncol 143:1555–1562CrossRefPubMedGoogle Scholar
  20. 20.
    Valcavi R, Riganti F, Bertani A et al (2010) Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid 20:1253–1261CrossRefPubMedGoogle Scholar
  21. 21.
    Feng B, Liang P, Cheng Z et al (2012) Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur J Endocrinol 166:1031–1037CrossRefPubMedGoogle Scholar
  22. 22.
    Yue W, Wang S, Wang B et al (2013) Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur J Radiol 82:e11–16CrossRefGoogle Scholar
  23. 23.
    Dodd GD 3rd, Dodd NA, Lanctot AC et al (2013) Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model. Radiology 267:129–136CrossRefPubMedGoogle Scholar
  24. 24.
    Qian GJ, Wang N, Shen Q et al (2012) Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies. Eur Radiol 22:1983–1990CrossRefPubMedGoogle Scholar
  25. 25.
    Li C, Li C, Ge H et al (2018) Technical analysis of US imaging for precise microwave ablation for benign breast tumours. Int J Hyperth 34:1179–1185CrossRefGoogle Scholar
  26. 26.
    Baek JH, Kim YS, Sung JY et al (2011) Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol 197:W331–336CrossRefGoogle Scholar
  27. 27.
    Monchik JM, Donatini G, Iannuccilli J et al (2006) Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244:296–304CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Lee JH, Kim YS, Lee D et al (2010) Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg 34:1488–1493. CrossRefPubMedGoogle Scholar
  29. 29.
    Zhang L, Zhou W, Zhan W et al (2018) Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg 42:2476–2484CrossRefPubMedGoogle Scholar
  30. 30.
    Uchida H, Imai T, Kikumori T et al (2013) Long-term results of surgery for papillary thyroid carcinoma with local recurrence. Surg Today 43:848–853CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2018

Authors and Affiliations

  • Wei Zhou
    • 1
  • Yudong Chen
    • 1
  • Lu Zhang
    • 1
  • Xiaofeng Ni
    • 1
  • Shangyan Xu
    • 1
  • Weiwei Zhan
    • 1
    Email author
  1. 1.Department of Ultrasound, Rui Jin Hospital, School of MedicineShanghai Jiao Tong UniversityShanghaiChina

Personalised recommendations